GB928302A - í¸-pregnene compounds - Google Patents

í¸-pregnene compounds

Info

Publication number
GB928302A
GB928302A GB43100/61A GB4310061A GB928302A GB 928302 A GB928302 A GB 928302A GB 43100/61 A GB43100/61 A GB 43100/61A GB 4310061 A GB4310061 A GB 4310061A GB 928302 A GB928302 A GB 928302A
Authority
GB
United Kingdom
Prior art keywords
hydroxy
compound
converted
methyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB43100/61A
Other languages
English (en)
Inventor
David H Gould
Hans Reimann
Lawrence E Finckenor
Cecil H Robinson
Eugene Oliveto
Elliot L Shapiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US743492A external-priority patent/US2894963A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of GB928302A publication Critical patent/GB928302A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
GB43100/61A 1958-06-20 1959-06-11 í¸-pregnene compounds Expired GB928302A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US743492A US2894963A (en) 1958-06-20 1958-06-20 9,11-dihalogeno-4-pregnenes and 1,4-pregnadienes
CA775651 1959-05-30
GB20033/59A GB928301A (en) 1958-06-20 1959-06-11 9, 11-dihalogeno steroids

Publications (1)

Publication Number Publication Date
GB928302A true GB928302A (en) 1963-06-12

Family

ID=25673299

Family Applications (2)

Application Number Title Priority Date Filing Date
GB20033/59A Expired GB928301A (en) 1958-06-20 1959-06-11 9, 11-dihalogeno steroids
GB43100/61A Expired GB928302A (en) 1958-06-20 1959-06-11 í¸-pregnene compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB20033/59A Expired GB928301A (en) 1958-06-20 1959-06-11 9, 11-dihalogeno steroids

Country Status (7)

Country Link
BE (1) BE579900A (cs)
CH (1) CH386415A (cs)
DK (1) DK118874B (cs)
ES (1) ES250249A1 (cs)
FR (1) FR564M (cs)
GB (2) GB928301A (cs)
NL (1) NL106036C (cs)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207151B2 (en) 2008-05-28 2012-06-26 Validus Biopharma Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3397213A (en) * 1966-01-12 1968-08-13 Squibb & Sons Inc 12 methyl-9, 11-dihaloprogesterones
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10857161B2 (en) 2008-05-28 2020-12-08 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US8334279B2 (en) 2008-05-28 2012-12-18 Validus Genetics Non-hormonal steroid modulators of NF-κB for treatment of disease
US8673887B2 (en) 2008-05-28 2014-03-18 Reveragen Biopharma, Inc Non-hormonal steroid modulators of NF-kB for treatment of disease
US8207151B2 (en) 2008-05-28 2012-06-26 Validus Biopharma Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US9434758B2 (en) 2008-05-28 2016-09-06 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US9649320B2 (en) 2008-05-28 2017-05-16 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US11833159B2 (en) 2008-05-28 2023-12-05 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US10206933B2 (en) 2008-05-28 2019-02-19 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10000525B2 (en) 2010-04-05 2018-06-19 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11690853B2 (en) 2015-06-29 2023-07-04 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κβ for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US11471471B2 (en) 2019-03-07 2022-10-18 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US12201639B2 (en) 2019-03-07 2025-01-21 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
ES250249A1 (es) 1960-01-16
NL106036C (cs) 1963-09-16
DK118874B (da) 1970-10-19
BE579900A (fr) 1959-10-16
GB928301A (en) 1963-06-12
FR564M (cs) 1961-06-05
CH386415A (fr) 1965-01-15

Similar Documents

Publication Publication Date Title
US3087938A (en) 17alpha-chloro and 17alpha-bromo-progesterones
GB928302A (en) í¸-pregnene compounds
US3164618A (en) Alkylated steroids
GB869511A (en) Improvements in or relating to steroids and the manufacture thereof
US3312692A (en) 16-alkylene progesterones and intermediates formed in the production thereof
US3009933A (en) Process for the manufacture of 9alpha, 11beta-dihalogenated steroids
US3184484A (en) 5, 10-methylene-19-nor- and 5, 10-seco-5, 19-cyclo-10-fluoro-androstenes and pregnenes and processes for their preparation
US3290338A (en) 16-alkylprogesterones and their 9alpha, 11beta-dihalogeno analogs
US3014938A (en) Preparation of 16, 21-diacetate derivative of cyclopentanophenanthrene compounds
US3168537A (en) Process for the manufacture of 16-alkylidene-17alpha-alkanoyloxyprogesterones
US3519619A (en) 16-alkylidene pregnanes and process for their manufacture
US3131200A (en) C-ring halogenated progesterones
US3538130A (en) Substituted methylene steroids and their preparation
US3009938A (en) Process for the manufacture of halogenated steroids
US3009932A (en) 6-fluoro-9alpha, 11beta- 21-trihalo-progesterones
US3047596A (en) 6alpha-halogen-9alpha-halogen-delta-pregnadiene-3-one compounds
US2963495A (en) 12 alpha-halo-3, 11-oxygenated-17alpha-hydroxy-20 oxo steroids of the pregnane series
GB959377A (en) Dioxy steroids and processes for their preparation
USRE28369E (en) Atcc-zxs
US3828083A (en) Novel 6alpha,16alpha-dimethyl steroids
US3009929A (en) 9, 11-halogenated progestins
US3438977A (en) 6,7-methylene and 6,7-halomethylene pregnanes and 19-norpregnanes and process for their preparation
US3005817A (en) 12alpha-halo-delta20(22)-furostene-3beta, 26-diol-11-one 3, 26-diacylate and preparation thereof
US3069420A (en) 16alpha, 17alpha-cyclocarbonate esters of 16alpha, 17alpha-dihydroxy steroids
US3138589A (en) Process for the production of 6-halo-3-keto-delta4, 6-steroids